Literature DB >> 25951106

Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression.

Mustafa Ozen1, Omer Faruk Karatas, Sukru Gulluoglu, Omer Faruk Bayrak, Serhat Sevli, Esra Guzel, Isin D Ekici, Turhan Caskurlu, Mustafa Solak, Chad J Creighton, Michael Ittmann.   

Abstract

We aimed to perform functional analysis of miR-145-5p in prostate cancer (PCa) cells and to identify targets of miR-145-5p for understanding its role in PCa pathogenesis. PC3, DU145, LNCaP PCa, and PNT1a nontumorigenic prostate cell lines were utilized for functional analysis of miR-145-5p. Its overexpression caused inhibition of proliferation through apoptosis and reduced migration in PCa cells. SOX2 expression was significantly decreased in both mRNA and protein level in miR-145-5p-overexpressed PCa cells. We proposed that miR-145-5p, being an important regulator of SOX2, carries a crucial role in PCa tumorigenesis.

Entities:  

Keywords:  Cancer stem cell; Prostate cancer; SOX2; Stem cell marker; hsa-miR-145–5p

Mesh:

Substances:

Year:  2015        PMID: 25951106     DOI: 10.3109/07357907.2015.1025407

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  38 in total

Review 1.  Molecular mechanisms involving prostate cancer racial disparity.

Authors:  Cansu Karakas; Cassie Wang; Fangming Deng; Hongying Huang; Dongwen Wang; Peng Lee
Journal:  Am J Clin Exp Urol       Date:  2017-11-09

Review 2.  The roles of microRNAs in the progression of castration-resistant prostate cancer.

Authors:  Satoko Kojima; Yusuke Goto; Yukio Naya
Journal:  J Hum Genet       Date:  2016-06-09       Impact factor: 3.172

3.  AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation.

Authors:  Zhen Wang; Li Kang; Huifang Zhang; Yuanyong Huang; Lan Fang; Menghan Li; Peter J Brown; Cheryl H Arrowsmith; Jiwen Li; Jiemin Wong
Journal:  Oncogene       Date:  2019-03-20       Impact factor: 9.867

4.  Diagnostic and prognostic significance of serum miR-145-5p expression in glioblastoma.

Authors:  Yao Zhang; Wei-Wei Ta; Peng-Fei Sun; Yi-Fan Meng; Cheng-Zong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

5.  MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3'-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein.

Authors:  Zhe Yang; Jiong Li; Guoxing Feng; Shan Gao; Yuan Wang; Shuqin Zhang; Yunxia Liu; Lihong Ye; Yueguo Li; Xiaodong Zhang
Journal:  J Biol Chem       Date:  2017-01-19       Impact factor: 5.157

6.  MiR-145 suppresses the motility of prostate cancer cells by targeting cadherin-2.

Authors:  Huixuan Zeng; Yishan Huang; Qiuling Liu; Hongjiao Liu; Tianzhu Long; Cairong Zhu; Xiaoping Wu
Journal:  Mol Cell Biochem       Date:  2021-05-27       Impact factor: 3.396

Review 7.  Circular RNAs and their participation in stemness of cancer.

Authors:  Francisco Alejandro Lagunas-Rangel
Journal:  Med Oncol       Date:  2020-04-07       Impact factor: 3.064

8.  Expression of miR-145 and Its Target Proteins Are Regulated by miR-29b in Differentiated Neurons.

Authors:  Abhishek Jauhari; Tanisha Singh; Sanjay Yadav
Journal:  Mol Neurobiol       Date:  2018-04-04       Impact factor: 5.590

9.  MiR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19.

Authors:  Zhe Sun; Ai Zhang; Tao Jiang; Zhaodong Du; Chengye Che; Fang Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  Identification of miRNA signatures and their therapeutic potentials in prostate cancer.

Authors:  Abdullah Karadag; Ata Ozen; Mete Ozkurt; Cavit Can; Ibrahim Bozgeyik; Selda Kabadere; Ruhi Uyar
Journal:  Mol Biol Rep       Date:  2021-07-27       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.